Lung Cancer Screening

Low-dose CT screening for high-risk individuals to detect lung cancer early

Lung cancer carries the highest cancer mortality worldwide — largely because most cases are diagnosed at an advanced stage. Low-dose CT lung screening identifies early-stage lung cancers in high-risk individuals before symptoms develop, when curative treatment is most effective.

Recommended annually for current or former heavy smokers aged 50–80 and those with other significant lung cancer risk factors, LDCT screening has been shown to reduce lung cancer mortality by up to 20%.

Key Benefits

Detects early-stage lung cancers before symptoms appear
Low radiation dose — significantly less than standard CT
Reduces lung cancer mortality in high-risk individuals
Identifies incidental pulmonary findings needing investigation

Is This Treatment Right For You?

Current smokers aged 50–80 with a 20+ pack-year history
Former heavy smokers who quit within the last 15 years
High-risk individuals with occupational lung exposures

What to Expect

Risk Assessment

Smoking history, pack-years and occupational exposures quantified.

LDCT Scan

Low-dose CT of the chest performed; takes under 10 minutes.

Radiologist Reporting

Images reviewed using Lung-RADS classification system.

Results & Follow-Up

Results communicated; surveillance or biopsy pathway initiated if needed.

Recovery & Aftercare

No downtime — LDCT is a non-invasive imaging procedure.

Frequently Asked Questions

Is low-dose CT safe to have annually?

Yes — LDCT uses approximately 1.5 mSv of radiation, significantly less than a standard chest CT, and annual screening is approved for high-risk individuals.

What happens if a nodule is found?

Most detected nodules are benign; a Lung-RADS scoring system guides follow-up intervals, with biopsy only for those with features suggesting malignancy.